NDC 80425-0320-01 - Escitalopram
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0320
- Requested NDC
- 80425-0320-01
- Package NDCs from labels
- 80425-0320-1, 80425-0320-2, 80425-0320-3, 80425-0320-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Escitalopram - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0320-1 | Escitalopram | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 80425-0320-2 | Escitalopram | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 | |
| 80425-0320-3 | Escitalopram | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0320 | ESCITALOPRAM TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f914fec5-4ce7-794d-e053-6294a90a7cc5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0320-1 | EA - Each | 80425-0320 | 46dcd70d-fdea-4981-8764-ddbaaccae7cc | 1 | 2023-06-06 |
| 80425-0320-2 | EA - Each | 80425-0320 | 7cff7ce0-3352-459a-b266-2a305e782f8f | 1 | 2023-06-06 |
| 80425-0320-3 | EA - Each | 80425-0320 | 0b8ccf87-87c4-429f-9b0d-52dba9ec86d6 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Escitalopram | ESCITALOPRAM | A-S Medication Solutions | a0344290-6e12-46c4-a11c-5347a770adbe | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | ANDA078032 349332 5U85DBW7LO |
| escitalopram | ESCITALOPRAM | Torrent Pharmaceuticals Limited | 068bb338-23f3-4278-958b-c34b40456024 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram Oral Solution | ESCITALOPRAM ORAL | Chartwell Governmental & Specialty RX, LLC. | 45ed4d16-6358-40a1-9352-319e58f55e5d | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | f2b3b385-658d-5918-e053-2a95a90afcba | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351249 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | Northwind Health Company, LLC | f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | d9ba6c65-22bd-10c4-e053-2995a90ada2e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | dabf8bc0-5de6-edce-e053-2995a90a73c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | f2b7b0a6-481b-1f6f-e053-2a95a90a2d04 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA078032 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | addccf96-cc60-6045-e053-2a95a90aaac0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | c9f52332-8616-19d8-e053-2995a90ad753 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Northwind Health Company, LLC | da7feb56-5f5a-7487-e053-2995a90a119e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 351249 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Direct_Rx | f81e3858-f01e-1df6-e053-6394a90aef4f | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | QPharma, Inc. | 85fbcce8-a870-4f04-8a0e-a12e46eed3cf | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | QPharma, Inc. | e56e8d41-188c-5a6f-e053-2a95a90a70e6 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA078032 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | QPharma, Inc. | f682f991-1807-176a-e053-2995a90a3dfa | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| escitalopram oxalate | ESCITALOPRAM OXALATE | PD-Rx Pharmaceuticals, Inc. | b7670e51-8f44-4f64-b110-3f2f431a4032 | 2025-10-20 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Accord Healthcare Inc. | 84b2028d-eff4-434d-b71e-6a3c0812f625 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram Oxalate | ESCITALOPRAM | Cipla USA Inc. | 31ce0b82-58fe-44f3-8887-c55d8df1b773 | 2025-10-06 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| escitalopram | ESCITALOPRAM | Almatica Pharma LLC | c0401570-a3b0-bef2-7365-c23dc952b8b6 | 2025-08-31 | Boxed warning, Warnings, Adverse reactions | 5U85DBW7LO |
| ESCITALOPRAM OXALATE | ESCITALOPRAM | Ascent Pharmaceuticals, Inc | 1285841d-d9f8-49c6-9456-bf51c8e37271 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.